{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:49Z","timestamp":1792790929284,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20-GM103464"],"award-info":[{"award-number":["P20-GM103464"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30-GM114736"],"award-info":[{"award-number":["P30-GM114736"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54-GM104941"],"award-info":[{"award-number":["U54-GM104941"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","id":[{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","id":[{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>In vivo<\/jats:italic>\n                    positron emission tomography (PET) imaging is a key modality to evaluate disease status of brain tumors. In recent years, tremendous efforts have been made in developing PET imaging methods for pediatric brain tumors. Carbon-11 labelled tryptophan derivatives are feasible as PET imaging probes in brain tumor patients with activation of the kynurenine pathway, but the short half-life of carbon-11 limits its application. Using a transgenic mouse model for the sonic hedgehog (Shh) subgroup of medulloblastoma, here we evaluated the potential of the newly developed 1-(2-[\n                    <jats:sup>18<\/jats:sup>\n                    F]fluoroethyl)-L-tryptophan (1-L-[\n                    <jats:sup>18<\/jats:sup>\n                    F]FETrp) as a PET imaging probe for this common malignant pediatric brain tumor. 1-L-[\n                    <jats:sup>18<\/jats:sup>\n                    F]FETrp was synthesized on a PETCHEM automatic synthesizer with good chemical and radiochemical purities and enantiomeric excess values. Imaging was performed in tumor-bearing Smo\/Smo medulloblastoma mice with constitutive actvation of the Smoothened (Smo) receptor using a PerkinElmer G4 PET-X-Ray scanner. Medulloblastoma showed significant and specific accumulation of 1-L-[\n                    <jats:sup>18<\/jats:sup>\n                    F]FETrp. 1-L-[\n                    <jats:sup>18<\/jats:sup>\n                    F]FETrp also showed significantly higher tumor uptake than its D-enantiomer, 1-D-[\n                    <jats:sup>18<\/jats:sup>\n                    F]FETrp. The uptake of 1-L-[\n                    <jats:sup>18<\/jats:sup>\n                    F]FETrp in the normal brain tissue was low, suggesting that 1-L-[\n                    <jats:sup>18<\/jats:sup>\n                    F]FETrp may prove a valuable PET imaging probe for the Shh subgroup of medulloblastoma and possibly other pediatric and adult brain tumors.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-60728-6","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T06:03:15Z","timestamp":1583128995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["PET imaging of medulloblastoma with an 18F-labeled tryptophan analogue in a transgenic mouse model"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2270-133X","authenticated-orcid":false,"given":"Yangchun","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyi","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hancheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabinda K.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C.","family":"Chugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid A.","family":"Langhans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"60728_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2018.10.PEDS18377","volume":"23","author":"IF Pollack","year":"2019","unstructured":"Pollack, I. F., Agnihotri, S. & Broniscer, A. Childhood brain tumors: current management, biological insights, and future directions. J. Neurosurg. Pediatr. 23, 261\u2013273 (2019).","journal-title":"J. Neurosurg. Pediatr."},{"key":"60728_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0883073815587944","volume":"31","author":"E Roddy","year":"2016","unstructured":"Roddy, E. & Mueller, S. Late Effects of Treatment of Pediatric Central Nervous System Tumors. J. Child. Neurol. 31, 237\u2013254 (2016).","journal-title":"J. Child. Neurol."},{"key":"60728_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott, P. A. et al. Medulloblastoma. Nat. Rev. Dis. Prim. 5, 11 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"60728_CR4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3174\/ajnr.A3990","volume":"35","author":"S Perreault","year":"2014","unstructured":"Perreault, S. et al. MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am. J. Neuroradiol. 35, 1263\u20131269 (2014).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"60728_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3174\/ajnr.A5899","volume":"40","author":"M Iv","year":"2019","unstructured":"Iv, M. et al. MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma. AJNR Am. J. Neuroradiol. 40, 154\u2013161 (2019).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"60728_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/neuros\/nyx103","volume":"81","author":"JE Villanueva-Meyer","year":"2017","unstructured":"Villanueva-Meyer, J. E., Mabray, M. C. & Cha, S. Current Clinical Brain Tumor Imaging. Neurosurg. 81, 397\u2013415 (2017).","journal-title":"Neurosurg."},{"key":"60728_CR7","doi-asserted-by":"publisher","first-page":"175628641875986","DOI":"10.1177\/1756286418759865","volume":"11","author":"H Nandu","year":"2018","unstructured":"Nandu, H., Wen, P. Y. & Huang, R. Y. Imaging in neuro-oncology. Ther. Adv. Neurol. Disord. 11, 1756286418759865 (2018).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"60728_CR8","first-page":"148","volume":"12","author":"AK Demetriades","year":"2014","unstructured":"Demetriades, A. K., Almeida, A. C., Bhangoo, R. S. & Barrington, S. F. Applications of positron emission tomography in neuro-oncology: a clinical approach. Surg. 12, 148\u2013157 (2014).","journal-title":"Surg."},{"key":"60728_CR9","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1021\/mp500312t","volume":"11","author":"A Chiotellis","year":"2014","unstructured":"Chiotellis, A. et al. Synthesis and biological evaluation of (18)F-labeled Fluoroethoxy tryptophan analogues as potential PET tumor imaging agents. Mol. Pharm. 11, 3839\u20133851 (2014).","journal-title":"Mol. Pharm."},{"key":"60728_CR10","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.7150\/thno.19371","volume":"7","author":"BC Giglio","year":"2017","unstructured":"Giglio, B. C. et al. Synthesis of 5-[(18)F]Fluoro-alpha-methyl Tryptophan: New Trp Based PET Agents. Theranostics 7, 1524\u20131530 (2017).","journal-title":"Theranostics"},{"key":"60728_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.nucmedbio.2013.04.013","volume":"40","author":"S He","year":"2013","unstructured":"He, S. et al. Radiosynthesis and biological evaluation of 5-(3-[18F]fluoropropyloxy)-L-tryptophan for tumor PET imaging. Nucl. Med. Biol. 40, 801\u2013807 (2013).","journal-title":"Nucl. Med. Biol."},{"key":"60728_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.nucmedbio.2016.02.001","volume":"43","author":"X Huang","year":"2016","unstructured":"Huang, X., Xiao, X., Gillies, R. J. & Tian, H. Design and automated production of 11C-alpha-methyl-l-tryptophan (11C-AMT). Nucl. Med. Biol. 43, 303\u2013308 (2016).","journal-title":"Nucl. Med. Biol."},{"key":"60728_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.apradiso.2009.10.007","volume":"68","author":"R Li","year":"2010","unstructured":"Li, R. et al. Synthesis and evaluation of l-5-(2-[(18)F]fluoroethoxy)tryptophan as a new PET tracer. Appl. Radiat. Isot. 68, 303\u2013308 (2010).","journal-title":"Appl. Radiat. Isot."},{"key":"60728_CR14","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/jlcr.3648","volume":"61","author":"P Nordeman","year":"2018","unstructured":"Nordeman, P. et al. Automated GMP-production of alpha-[(11) C]methyl-L-tryptophan using a tracer production system (TPS). J. Label. Comp. Radiopharm. 61, 1106\u20131109 (2018).","journal-title":"J. Label. Comp. Radiopharm."},{"key":"60728_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.apradiso.2011.11.062","volume":"70","author":"T Sun","year":"2012","unstructured":"Sun, T. et al. Radiosynthesis of 1-[18F]fluoroethyl-L-tryptophan as a novel potential amino acid PET tracer. Appl. Radiat. Isot. 70, 676\u2013680 (2012).","journal-title":"Appl. Radiat. Isot."},{"key":"60728_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nucmedbio.2017.05.001","volume":"51","author":"T Tang","year":"2017","unstructured":"Tang, T. et al. Preparation and evaluation of L- and D-5-[(18)F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases. Nucl. Med. Biol. 51, 10\u201317 (2017).","journal-title":"Nucl. Med. Biol."},{"key":"60728_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1021\/acs.jmedchem.7b01245","volume":"61","author":"BD Zlatopolskiy","year":"2018","unstructured":"Zlatopolskiy, B. D. et al. Discovery of 7-[(18)F]Fluorotryptophan as a Novel Positron Emission Tomography (PET) Probe for the Visualization of Tryptophan Metabolism in Vivo. J. Med. Chem. 61, 189\u2013206 (2018).","journal-title":"J. Med. Chem."},{"key":"60728_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.jcbfm.9600199","volume":"26","author":"C Juhasz","year":"2006","unstructured":"Juhasz, C. et al. In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors. J. Cereb. Blood Flow. Metab. 26, 345\u2013357 (2006).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"60728_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11060-010-0327-1","volume":"102","author":"C Juhasz","year":"2011","unstructured":"Juhasz, C. et al. Differential kinetics of alpha-[11C]methyl-L-tryptophan on PET in low-grade brain tumors. J. Neurooncol 102, 409\u2013415 (2011).","journal-title":"J. Neurooncol"},{"key":"60728_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/RLU.0b013e318251e458","volume":"37","author":"C Juhasz","year":"2012","unstructured":"Juhasz, C. et al. Quantitative PET imaging of tryptophan accumulation in gliomas and remote cortex: correlation with tumor proliferative activity. Clin. Nucl. Med. 37, 838\u2013842 (2012).","journal-title":"Clin. Nucl. Med."},{"key":"60728_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11307-009-0225-0","volume":"11","author":"CE Batista","year":"2009","unstructured":"Batista, C. E. et al. Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. Mol. Imaging Biol. 11, 460\u2013466 (2009).","journal-title":"Mol. Imaging Biol."},{"key":"60728_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11307-007-0090-7","volume":"9","author":"F Peng","year":"2007","unstructured":"Peng, F. et al. Assessment of progression and treatment response of optic pathway glioma with positron emission tomography using alpha-[(11)C]methyl-L-tryptophan. Mol. Imaging Biol. 9, 106\u2013109 (2007).","journal-title":"Mol. Imaging Biol."},{"key":"60728_CR23","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2967\/jnumed.111.097881","volume":"53","author":"B Alkonyi","year":"2012","unstructured":"Alkonyi, B. et al. Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of alpha-11C-methyl-L-tryptophan PET. J. Nucl. Med. 53, 1058\u20131064 (2012).","journal-title":"J. Nucl. Med."},{"key":"60728_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-015-0045-1","volume":"15","author":"JW Jeong","year":"2015","unstructured":"Jeong, J. W. et al. Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas. Cancer Imaging 15, 10 (2015).","journal-title":"Cancer Imaging"},{"key":"60728_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11060-018-03013-x","volume":"141","author":"RV Lukas","year":"2019","unstructured":"Lukas, R. V. et al. Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod. J. Neurooncol 141, 111\u2013120 (2019).","journal-title":"J. Neurooncol"},{"key":"60728_CR26","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1021\/acs.jmedchem.5b00461","volume":"58","author":"AB Dounay","year":"2015","unstructured":"Dounay, A. B., Tuttle, J. B. & Verhoest, P. R. Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway. J. Med. Chem. 58, 8762\u20138782 (2015).","journal-title":"J. Med. Chem."},{"key":"60728_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L Vecsei","year":"2013","unstructured":"Vecsei, L., Szalardy, L., Fulop, F. & Toldi, J. Kynurenines in the CNS: recent advances and new questions. Nat. Rev. Drug. Discov. 12, 64\u201382 (2013).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"60728_CR28","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-12-0549","volume":"72","author":"S Adams","year":"2012","unstructured":"Adams, S. et al. The kynurenine pathway in brain tumor pathogenesis. Cancer Res. 72, 5649\u20135657 (2012).","journal-title":"Cancer Res."},{"key":"60728_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1536012116644881","volume":"15","author":"AR Guastella","year":"2016","unstructured":"Guastella, A. R. et al. Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma. Mol. Imaging 15, 1\u201311 (2016).","journal-title":"Mol. Imaging"},{"key":"60728_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/neuonc\/nov225.38","volume":"17","author":"E Bosnyak","year":"2015","unstructured":"Bosnyak, E. et al. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro Oncol. 17, 1284\u20131292 (2015).","journal-title":"Neuro Oncol."},{"key":"60728_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3148-1","volume":"17","author":"EH Panosyan","year":"2017","unstructured":"Panosyan, E. H., Lin, H. J., Koster, J. & Lasky, J. L. III. In search of druggable targets for GBM amino acid metabolism. BMC Cancer 17, 162 (2017).","journal-title":"BMC Cancer"},{"key":"60728_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2967\/jnumed.116.179994","volume":"58","author":"SK Michelhaugh","year":"2017","unstructured":"Michelhaugh, S. K. et al. Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and alpha-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts. J. Nucl. Med. 58, 208\u2013213 (2017).","journal-title":"J. Nucl. Med."},{"key":"60728_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11307-016-1024-z","volume":"19","author":"Y Xin","year":"2017","unstructured":"Xin, Y. & Cai, H. Improved Radiosynthesis and Biological Evaluations of L- and D-1-[(18)F]Fluoroethyl-Tryptophan for PET Imaging of IDO-Mediated Kynurenine Pathway of Tryptophan Metabolism. Mol. Imaging Biol. 19, 589\u2013598 (2017).","journal-title":"Mol. Imaging Biol."},{"key":"60728_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nucmedbio.2016.03.001","volume":"43","author":"J Henrottin","year":"2016","unstructured":"Henrottin, J. et al. Fully automated radiosynthesis of N(1)-[(18)F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging. Nucl. Med. Biol. 43, 379\u2013389 (2016).","journal-title":"Nucl. Med. Biol."},{"key":"60728_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2967\/jnumed.111.096289","volume":"53","author":"SD Kramer","year":"2012","unstructured":"Kramer, S. D. et al. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET. J. Nucl. Med. 53, 434\u2013442 (2012).","journal-title":"J. Nucl. Med."},{"key":"60728_CR36","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1021\/acs.jmedchem.6b00057","volume":"59","author":"A Chiotellis","year":"2016","unstructured":"Chiotellis, A. et al. Synthesis, Radiolabeling, and Biological Evaluation of 5-Hydroxy-2-[(18)F]fluoroalkyl-tryptophan Analogues as Potential PET Radiotracers for Tumor Imaging. J. Med. Chem. 59, 5324\u20135340 (2016).","journal-title":"J. Med. Chem."},{"key":"60728_CR37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","volume":"29","author":"TN Phoenix","year":"2016","unstructured":"Phoenix, T. N. et al. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. Cancer Cell 29, 508\u2013522 (2016).","journal-title":"Cancer Cell"},{"key":"60728_CR38","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1158\/0008-5472.CAN-07-5092","volume":"68","author":"BA Hatton","year":"2008","unstructured":"Hatton, B. A. et al. The Smo\/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Res. 68, 1768\u20131776 (2008).","journal-title":"Cancer Res."},{"key":"60728_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40336-017-0225-z","volume":"5","author":"CP Filss","year":"2017","unstructured":"Filss, C. P., Cicone, F., Shah, N. J., Galldiks, N. & Langen, K. J. Amino acid PET and MR perfusion imaging in brain tumours. Clin. Transl. Imaging 5, 209\u2013223 (2017).","journal-title":"Clin. Transl. Imaging"},{"key":"60728_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2967\/jnumed.112.113100","volume":"54","author":"C Huang","year":"2013","unstructured":"Huang, C. & McConathy, J. Radiolabeled amino acids for oncologic imaging. J. Nucl. Med. 54, 1007\u20131010 (2013).","journal-title":"J. Nucl. Med."},{"key":"60728_CR41","doi-asserted-by":"crossref","unstructured":"Heng, B. et al. Understanding the role of the kynurenine pathway in human breast cancer immunobiology. Oncotarget 7 (2016).","DOI":"10.18632\/oncotarget.6467"},{"key":"60728_CR42","doi-asserted-by":"crossref","unstructured":"Sforzini, L., Nettis, M. A., Mondelli, V. & Pariante, C. M. Inflammation in cancer and depression: a starring role for the kynurenine pathway. Psychopharmacology (Berl) (2019).","DOI":"10.1007\/s00213-019-05200-8"},{"key":"60728_CR43","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.2967\/jnumed.114.140699","volume":"55","author":"IA Burger","year":"2014","unstructured":"Burger, I. A. et al. First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET\/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma. J. Nucl. Med. 55, 1778\u20131785 (2014).","journal-title":"J. Nucl. Med."},{"key":"60728_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.jcbfm.9600065","volume":"25","author":"KJ Langen","year":"2005","unstructured":"Langen, K. J. et al. Preferred stereoselective transport of the D-isomer of cis-4-[18F]fluoro-proline at the blood-brain barrier. J. Cereb. Blood Flow. Metab. 25, 607\u2013616 (2005).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"60728_CR45","first-page":"679","volume":"47","author":"H Tsukada","year":"2006","unstructured":"Tsukada, H. et al. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine. J. Nucl. Med. 47, 679\u2013688 (2006).","journal-title":"J. Nucl. Med."},{"key":"60728_CR46","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11307-019-01327-4","volume":"6","author":"Y Xin","year":"2019","unstructured":"Xin, Y. et al. Evaluation of L-1-[(18)F]Fluoroethyl-Tryptophan for PET Imaging of Cancer. Mol. Imaging Biol. 6, 1138\u20131146 (2019).","journal-title":"Mol. Imaging Biol."},{"key":"60728_CR47","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone, T. W. & Darlington, L. G. Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug. Discov. 1, 609\u2013620 (2002).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"60728_CR48","doi-asserted-by":"publisher","first-page":"52900","DOI":"10.18632\/oncotarget.9284","volume":"7","author":"V Folgiero","year":"2016","unstructured":"Folgiero, V. et al. IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma. Oncotarget 7, 52900\u201352911 (2016).","journal-title":"Oncotarget"},{"key":"60728_CR49","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1124\/mol.111.077305","volume":"81","author":"DP Dever","year":"2012","unstructured":"Dever, D. P. & Opanashuk, L. A. The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells. Mol. Pharmacol. 81, 669\u2013678 (2012).","journal-title":"Mol. Pharmacol."},{"key":"60728_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.devcel.2017.10.011","volume":"43","author":"CC Wu","year":"2017","unstructured":"Wu, C. C. et al. mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma. Dev. Cell 43, 673\u2013688 (2017).","journal-title":"Dev. Cell"},{"key":"60728_CR51","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/ijms19071838","volume":"19","author":"J Aldaregia","year":"2018","unstructured":"Aldaregia, J., Odriozola, A., Matheu, A. & Garcia, I. Targeting mTOR as a Therapeutic Approach in Medulloblastoma. Int. J. Mol. Sci. 19, 1838 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"60728_CR52","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-017-1753-3","volume":"134","author":"JE Neumann","year":"2017","unstructured":"Neumann, J. E., Swartling, F. J. & Schuller, U. Medulloblastoma: experimental models and reality. Acta Neuropathol. 134, 679\u2013689 (2017).","journal-title":"Acta Neuropathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60728-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:54:20Z","timestamp":1670295260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60728-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60728"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60728-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3800"}}